Core Viewpoint - 港通医疗 (301515) experienced a significant decline in stock price, closing at 20.79 yuan on November 21, 2025, down 7.27% from the previous day [1] Financial Performance - For the first three quarters of 2025, the company reported a main revenue of 344 million yuan, a year-on-year decrease of 30.06% [5] - The net profit attributable to shareholders was -10.21 million yuan, a decline of 150.92% year-on-year [5] - The third quarter of 2025 saw a single-quarter main revenue of 79.12 million yuan, an increase of 42.81% year-on-year, but the net profit was still negative at -1.80 million yuan, down 138.94% year-on-year [5] Market Activity - On November 21, 2025, the main funds saw a net outflow of 332,600 yuan, accounting for 0.63% of the total transaction amount [2] - Retail investors experienced a net outflow of 679,000 yuan, representing 1.29% of the total transaction amount [2] - The financing balance on November 21 was 33.06 million yuan, with a net repayment of 387,900 yuan [3] Company Metrics - 港通医疗's total market value is 2.058 billion yuan, significantly lower than the industry average of 10.952 billion yuan [5] - The company has a negative net profit margin of -3.44%, compared to the industry average of 9.57% [5] - The company's gross profit margin stands at 22.45%, while the industry average is 51.22% [5]
港通医疗（301515）11月21日主力资金净卖出33.26万元